Gonorrhoea vaccine - SIGA
Alternative Names: Neisseria gonorrhoeae vaccine - SIGALatest Information Update: 22 Sep 2014
At a glance
- Originator SIGA Technologies
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gonorrhoea
Most Recent Events
- 27 Apr 2005 Discontinued - Preclinical for Gonorrhoea in USA (unspecified route)
- 03 Feb 2004 Preclinical trials in Gonorrhoea in USA (unspecified route)
- 20 Oct 2000 Preclinical development for Gonorrhoea in USA (Unknown route)